Robert Califf
@robcaliff.bsky.social
860 followers 59 following 350 posts

Robert McKinnon Califf is an American cardiologist who served as the 25th commissioner of food and drugs from 2016 to 2017 and again from 2022 to 2025.

Source: Wikipedia
Medicine 47%
Economics 27%
Posts Media Videos Starter Packs

erictopol.bsky.social
Waning immunity. A significant Covid wave in England. No new variant.
Thanks Prof Pagel for highlighting and contextualizing

Reposted by Robert M. Califf

drdebhoury.bsky.social
From the 6 Surgeon Generals who served across administrations since President Bush: "Secretary Kennedy is entitled to his views. But he is not entitled to put people’s health at risk. He has rejected science, misled the public and compromised the health of Americans."
Opinion | Six surgeons general: It’s our duty to warn the nation about RFK Jr.
We took an oath to declare dangers when we found them. We’re doing that again today.
www.washingtonpost.com

Reposted by Robert M. Califf

robcaliff.bsky.social
Dr Wachter gives a good summary of the evolving issues in LLM, textbooks, digital tools and decision support.

open.substack.com/pub/robertwa...
Medicine’s AI Knowledge War Heats Up
The Battlegrounds May Surprise You
open.substack.com

robcaliff.bsky.social
Some real wisdom here: "It’s far easier to focus on individual mothers, and the unproven promise of miracle drugs, than to create a system that supports us all."

www.nytimes.com/2025/09/27/o...
Opinion | How Moms Got Caught in Trump’s Cross Hairs
www.nytimes.com

robcaliff.bsky.social
important book. Sobering in terms of pointing out that the issue is mostly the food environment, heavily subsidized by our tax money. Redirecting it will require both will to change and regulation. California has started.

www.foodpolitics.com?lctg=333222006
Food Politics by Marion Nestle
www.foodpolitics.com

robcaliff.bsky.social
There are reasons that California's health status is better than most of U.S. Other states could learn from this.

robcaliff.bsky.social
Since its generic there are no deep pockets in industry to fund such a trial. Let's get the answers!

robcaliff.bsky.social
Given the prominence this is being given from the top, i hope NIH or PCORI will fund an adequate sized, high quality clinical trial to define the benefit-risk profile of this intervention to treat autism.

www.nytimes.com/2025/09/22/w...
What Is Leucovorin, the Medicine Being Approved for Autism Treatment?
www.nytimes.com

robcaliff.bsky.social
An opinion about the need to better understand the framing and decision making that impacts so much of preventive public health--"habits" and inconveniences to prevent low probability, but high impact future events in return for some up front risk.

substack.com/@robcaliff27...
Interventions for Low-Probability Events
Recently, I have been struggling to understand why so few people have taken the updated COVID booster when the benefit-risk calculation seems so straightforward.
substack.com

Reposted by Robert M. Califf

erictopol.bsky.social
That's right. It could have been worse.
Brace for more to come.

robcaliff.bsky.social
-at least with drugs there is evidence for benefits and risks--no requirement for such data on supplements, yet little is said about advertising practices.